<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:department>Infectious and Tropical Diseases</gtr:department><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/60D0212F-7AF6-4384-B740-6F2A48F0C6C3"><gtr:id>60D0212F-7AF6-4384-B740-6F2A48F0C6C3</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Andrew</gtr:otherNames><gtr:surname>Baker</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F76750E6-D3E0-49FE-AF75-EEDEE61210D9"><gtr:id>F76750E6-D3E0-49FE-AF75-EEDEE61210D9</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:surname>Croft</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/831B664D-5B6F-4251-A55B-355BEBF7BB78"><gtr:id>831B664D-5B6F-4251-A55B-355BEBF7BB78</gtr:id><gtr:firstName>Catherine</gtr:firstName><gtr:surname>Kettleborough</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6762A820-C729-41D7-8836-248C72628ADB"><gtr:id>6762A820-C729-41D7-8836-248C72628ADB</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:otherNames>Andrew</gtr:otherNames><gtr:surname>Osborne</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8D996A31-87F8-45CA-BFD0-5C0884F6EDBC"><gtr:id>8D996A31-87F8-45CA-BFD0-5C0884F6EDBC</gtr:id><gtr:firstName>Andy</gtr:firstName><gtr:surname>Merritt</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1000779"><gtr:id>12C40933-E08B-4FA4-BA25-7205326A0614</gtr:id><gtr:title>Development of an antimalarial drug that targets the Plasmodium falciparum cGMP-dependent protein kinase</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1000779</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2012-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>341773</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Technology (MRCT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRCT Centre for Therapeutics Discovery (CTD)</gtr:department><gtr:description>Development of drugs targeting the Plasmodium cGMP-dependent protein kinase</gtr:description><gtr:id>52005222-7AC2-46DE-87BA-324EA5AE042F</gtr:id><gtr:impact>This collaboration is multi-disciplinary and involves, chemistry, drug discover biology, parasitology and biochemistry.</gtr:impact><gtr:outcomeId>SZjHYvpjp3B-1</gtr:outcomeId><gtr:partnerContribution>An MRC Technology-based scientist if the project manager for the DPFS-funded partnership. MRC Technology have generated compounds, provided chemistry expertise and drug discovery biology expertise.</gtr:partnerContribution><gtr:piContribution>An LSHTM-based scientist is the PI on the DPFS funded partnership. An LSHTM-based research fellow responsible for testing compounds in vitro. An LSHTM-based research assistant is responsible for testing compounds against the parasite in vitro and in vivo.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Biology In Action for A level Students</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>764B04E2-5D41-4499-8506-18C7FD32ACEF</gtr:id><gtr:impact>I was one of several invited scientists who gave general talks on their research area and I included details of this MRC funded project. There were 650 A level students who attended and it was part of the 'Biology in Action' series organised by The Training Partnership. http://www.thetrainingpartnership.org.uk/study-days/subjects/biology/
 This session was held at the UCL Institute of Education on 2nd March 2016.</gtr:impact><gtr:outcomeId>58b57a9a5aaea7.18089625</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.thetrainingpartnership.org.uk/study-days/subjects/biology/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>337000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>094752/Z/10/Z</gtr:fundingRef><gtr:id>4427C39B-B64A-4790-8FB8-4C68D9238290</gtr:id><gtr:outcomeId>MySpPCrqikZ</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>107000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Tres Cantos Open lab Foundation</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Tres Cantos Open Lab Foundation</gtr:fundingOrg><gtr:fundingRef>TC217</gtr:fundingRef><gtr:id>3F9AAF62-3BA1-437A-9A14-5AE5CBE2BCD0</gtr:id><gtr:outcomeId>58b575e0e94846.16880300</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSK Cofund</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>85AC2E82-7B79-442C-9E2F-3095CF409842</gtr:id><gtr:outcomeId>5644943a72d0f3.14151044</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>750000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Investigator Award</gtr:description><gtr:end>2020-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>EBB2E8B9-6DDD-4D29-997A-EC26BCE1BAAF</gtr:id><gtr:outcomeId>5644938a4a3d85.22452003</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E156F8A8-276F-4A2A-9A57-75E85CA8EECA</gtr:id><gtr:title>Malaria parasite cGMP-dependent protein kinase regulates blood stage merozoite secretory organelle discharge and egress.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0fe083004e64b1ae619da28337777e2"><gtr:id>d0fe083004e64b1ae619da28337777e2</gtr:id><gtr:otherNames>Collins CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_13709_29_23675297</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13F2E95A-6CA7-4D65-AF79-ACBCD6BD931D</gtr:id><gtr:title>Spatiotemporal and functional characterisation of the Plasmodium falciparum cGMP-dependent protein kinase.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61b1f6fb42e53b6af6c65eee96053493"><gtr:id>61b1f6fb42e53b6af6c65eee96053493</gtr:id><gtr:otherNames>Hopp CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13709_29_23139764</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0BD9022-A5AA-4B7B-89DE-5F36C7BC20EA</gtr:id><gtr:title>Imidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Parasite at Different Stages of Intracellular Development.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b53d6e471c849e174b17d32295691036"><gtr:id>b53d6e471c849e174b17d32295691036</gtr:id><gtr:otherNames>Green JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>58b577316e00b0.19707081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABD9FC7D-6420-4EAD-9A5B-5155DFCD0DA6</gtr:id><gtr:title>A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8efacc4c86ebd958c94b817a013f001a"><gtr:id>8efacc4c86ebd958c94b817a013f001a</gtr:id><gtr:otherNames>Baker DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>59b8efbcc4f054.11559566</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A653D95-4387-4323-972B-475FDCC173E4</gtr:id><gtr:title>Crystal structures of the carboxyl cGMP binding domain of the Plasmodium falciparum cGMP-dependent protein kinase reveal a novel capping triad crucial for merozoite egress.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d75c0bcc9053e9a07e2905e563de2ba8"><gtr:id>d75c0bcc9053e9a07e2905e563de2ba8</gtr:id><gtr:otherNames>Kim JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>564491b07b8a02.91668877</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22A75EE7-20F9-4389-9A76-7CC060044C94</gtr:id><gtr:title>Phosphoantigen Burst upon Plasmodium falciparum Schizont Rupture Can Distantly Activate V?9Vd2 T Cells.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/141e1c29fd0677ea44511e5a6db44e50"><gtr:id>141e1c29fd0677ea44511e5a6db44e50</gtr:id><gtr:otherNames>Guenot M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>564491b00967a5.89755747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A6C002D-2B7C-4F55-90A5-E0C1D80ED1E1</gtr:id><gtr:title>Phosphoproteomics reveals malaria parasite Protein Kinase G as a signalling hub regulating egress and invasion.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fbd39505663e1e77d042f13cfe7416c"><gtr:id>6fbd39505663e1e77d042f13cfe7416c</gtr:id><gtr:otherNames>Alam MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>564491b0331205.71996242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB6797DA-516D-481C-8EB2-4186E189BAC5</gtr:id><gtr:title>The role of cGMP signalling in regulating life cycle progression of Plasmodium.</gtr:title><gtr:parentPublicationTitle>Microbes and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61b1f6fb42e53b6af6c65eee96053493"><gtr:id>61b1f6fb42e53b6af6c65eee96053493</gtr:id><gtr:otherNames>Hopp CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1286-4579</gtr:issn><gtr:outcomeId>pm_13709_29_22613210</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4FDBDC7-CB75-4EC8-B7D0-DD1C9DAB430C</gtr:id><gtr:title>cAMP-Signalling Regulates Gametocyte-Infected Erythrocyte Deformability Required for Malaria Parasite Transmission.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92ec0f05dc2366d1c8eea402409901da"><gtr:id>92ec0f05dc2366d1c8eea402409901da</gtr:id><gtr:otherNames>Ramdani G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>564491b0565833.39819874</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40C7240E-DE30-43B3-A19D-95FF2631D3F9</gtr:id><gtr:title>Cyclic nucleotide signalling in malaria parasites.</gtr:title><gtr:parentPublicationTitle>Cellular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8efacc4c86ebd958c94b817a013f001a"><gtr:id>8efacc4c86ebd958c94b817a013f001a</gtr:id><gtr:otherNames>Baker DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1462-5814</gtr:issn><gtr:outcomeId>pm_13709_29_21176056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD7A3F22-D292-4EE8-BEC0-B8512EC0B2DF</gtr:id><gtr:title>Development of a transgenic Plasmodium berghei line (Pb pfpkg) expressing the P. falciparum cGMP-dependent protein kinase, a novel antimalarial drug target.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e74fa93145fbbe3f0f5dd4cb0ad89bb5"><gtr:id>e74fa93145fbbe3f0f5dd4cb0ad89bb5</gtr:id><gtr:otherNames>Tewari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_540e174e17437c1f8</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000779</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>